Literature DB >> 27659389

Effects of Treating Primary Aldosteronism on Renal Function.

Bart J Kramers1, Cornelis Kramers1,2, Jacques W M Lenders1,3, Jaap Deinum1.   

Abstract

Longstanding primary aldosteronism (PA) has deleterious effects on renal function, often masked until treatment (adrenalectomy or spironolactone) is initiated. It has been suggested that PA causes relative glomerular hyperfiltration, explaining the decline in estimated glomerular filtration rate (eGFR) after treatment. In this retrospective study, the authors retrieved the clinical characteristics and eGFR of 134 PA patients before and 6 months after treatment. Using multiple regression analysis, the predictors for eGFR decline and the predictors of ultimately attained renal function in 113 patients was assessed. eGFR declined by 15.3±14.2 (range 19-63) mL/min, independent predictors were pretreatment plasma aldosterone, eGFR, plasma renin, and plasma potassium. Independent predictors of ultimately attained eGFR after treatment were pretreatment plasma aldosterone, age, eGFR, and plasma potassium. Our findings lend support to the hypothesis that higher aldosterone levels cause relative glomerular hyperfiltration. The severity of pretreatment aldosterone excess is the most important risk factor for renal function decline. ©2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27659389      PMCID: PMC8031144          DOI: 10.1111/jch.12914

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  31 in total

Review 1.  Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications.

Authors:  M Epstein
Journal:  Am J Kidney Dis       Date:  2001-04       Impact factor: 8.860

2.  Effectiveness of aldosterone blockade in patients with diabetic nephropathy.

Authors:  Atsuhisa Sato; Koichi Hayashi; Mitsuhide Naruse; Takao Saruta
Journal:  Hypertension       Date:  2003-01       Impact factor: 10.190

3.  Aldosterone stimulates fibronectin synthesis in renal fibroblasts through mineralocorticoid receptor-dependent and independent mechanisms.

Authors:  Dong Chen; Zhiyong Chen; Chanyoung Park; Michael Centrella; Thomas McCarthy; Li Chen; Ahmed Al-Omari; Gilbert W Moeckel
Journal:  Gene       Date:  2013-08-30       Impact factor: 3.688

4.  Longitudinal study of living kidney donor glomerular dynamics after nephrectomy.

Authors:  Colin R Lenihan; Stephan Busque; Geraldine Derby; Kristina Blouch; Bryan D Myers; Jane C Tan
Journal:  J Clin Invest       Date:  2015-02-17       Impact factor: 14.808

5.  Relative glomerular hyperfiltration in primary aldosteronism.

Authors:  Jean Ribstein; Guilhem Du Cailar; Pierre Fesler; Albert Mimran
Journal:  J Am Soc Nephrol       Date:  2005-03-30       Impact factor: 10.121

6.  Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling.

Authors:  James D Stockand; J Gary Meszaros
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-09-05       Impact factor: 4.733

Review 7.  Vascular effects of aldosterone: sorting out the receptors and the ligands.

Authors:  Ross D Feldman; Robert Gros
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-12       Impact factor: 2.557

8.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

Authors:  John W Funder; Robert M Carey; Franco Mantero; M Hassan Murad; Martin Reincke; Hirotaka Shibata; Michael Stowasser; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2016-03-02       Impact factor: 5.958

9.  Relationships of plasma renin levels with renal function in patients with primary aldosteronism.

Authors:  Cristiana Catena; GianLuca Colussi; Elisa Nadalini; Alessandra Chiuch; Sara Baroselli; Roberta Lapenna; Leonardo A Sechi
Journal:  Clin J Am Soc Nephrol       Date:  2007-04-25       Impact factor: 8.237

10.  Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis.

Authors:  G M Magee; R W Bilous; C R Cardwell; S J Hunter; F Kee; D G Fogarty
Journal:  Diabetologia       Date:  2009-02-07       Impact factor: 10.122

View more
  10 in total

Review 1.  Primary aldosteronism: a common cause of resistant hypertension.

Authors:  Gregory A Kline; Ally P H Prebtani; Alexander A Leung; Ernesto L Schiffrin
Journal:  CMAJ       Date:  2017-06-05       Impact factor: 8.262

Review 2.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

3.  Transtubular potassium gradient predicts kidney function impairment after adrenalectomy in primary aldosteronism.

Authors:  Hung-Wei Liao; Shuo-Meng Wang; Chieh-Kai Chan; Yen-Hung Lin; Po-Chih Lin; Chen-Hsun Ho; Yu-Chun Liu; Jeff S Chueh; Vin-Cent Wu
Journal:  Ther Adv Chronic Dis       Date:  2020-08-27       Impact factor: 5.091

4.  Associations Between Changes in Plasma Renin Activity and Aldosterone Concentrations and Changes in Kidney Function After Treatment for Primary Aldosteronism.

Authors:  Yusuke Kobayashi; Tatsuya Haze; Yuichiro Yano; Kouichi Tamura; Isao Kurihara; Takamasa Ichijo; Takashi Yoneda; Takuyuki Katabami; Mika Tsuiki; Norio Wada; Yoshihiro Ogawa; Junji Kawashima; Masakatsu Sone; Nobuya Inagaki; Tetsuya Yamada; Ryuji Okamoto; Megumi Fujita; Kohei Kamemura; Koichi Yamamoto; Shoichiro Izawa; Akiyo Tanabe; Mitsuhide Naruse
Journal:  Kidney Int Rep       Date:  2020-06-20

5.  Effects of Treating Primary Aldosteronism on Renal Function.

Authors:  Bart J Kramers; Cornelis Kramers; Jacques W M Lenders; Jaap Deinum
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-09-23       Impact factor: 3.738

6.  Impact of primary aldosteronism on renal function in patients with type 2 diabetes.

Authors:  Sho Katsuragawa; Yuya Tsurutani; Tomoko Takiguchi; Jun Saito; Tetsuo Nishikawa
Journal:  J Diabetes Investig       Date:  2020-07-26       Impact factor: 4.232

7.  Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism.

Authors:  Yuta Tezuka; Adina F Turcu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-26       Impact factor: 5.555

8.  Age-Dependent Progression of Renal Dysfunction After Adrenalectomy for Aldosterone-Producing Adenomas in Japan.

Authors:  Masayuki Yoshioka; Yasuyo Nakajima; Tomoko Miyamoto; Takamichi Igarashi; Koji Sakamaki; Masako Akuzawa; Emi Ishida; Kazuhiko Horiguchi; Eijiro Yamada; Tsugumichi Saito; Atsushi Ozawa; Younosuke Shimomura; Isao Kobayashi; Yoshitaka Andou; Ken Shirabe; Masanobu Yamada
Journal:  J Endocr Soc       Date:  2018-12-17

9.  Incidence of Acute Kidney Injury after Adrenalectomy in Patients with Primary Aldosteronism.

Authors:  Jee Young Lee; Hyoungnae Kim; Hyung Woo Kim; Geun Woo Ryu; Yooju Nam; Seonyeong Lee; Young Su Joo; Sangmi Lee; Jung Tak Park; Seung Hyeok Han; Shin-Wook Kang; Tae-Hyun Yoo; Hae-Ryong Yun
Journal:  Electrolyte Blood Press       Date:  2019-12-31

10.  Prognosis of adrenalectomy guided by computed tomography versus adrenal vein sampling in patients with primary aldosteronism: A systematic review and meta-analysis.

Authors:  Yi Yan; Hui-Wen Sun; Yue Qi
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-01-22       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.